Deutsche Bank AG raised its position in shares of Ingevity Co. (NYSE:NGVT) by 8.4% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 65,995 shares of the company’s stock after acquiring an additional 5,110 shares during the period. Deutsche Bank AG’s holdings in Ingevity were worth $4,711,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds have also recently bought and sold shares of the company. Sei Investments Co. increased its position in Ingevity by 49.3% during the second quarter. Sei Investments Co. now owns 13,075 shares of the company’s stock valued at $1,076,000 after acquiring an additional 4,317 shares during the last quarter. Bank of New York Mellon Corp boosted its stake in shares of Ingevity by 4.6% during the second quarter. Bank of New York Mellon Corp now owns 528,657 shares of the company’s stock valued at $43,012,000 after purchasing an additional 23,148 shares during the period. Castleark Management LLC purchased a new stake in shares of Ingevity during the second quarter valued at $6,938,000. Advisory Services Network LLC purchased a new stake in shares of Ingevity during the second quarter valued at $30,000. Finally, Ararat Capital Management LP boosted its stake in shares of Ingevity by 23.6% during the second quarter. Ararat Capital Management LP now owns 180,619 shares of the company’s stock valued at $14,695,000 after purchasing an additional 34,484 shares during the period. Institutional investors and hedge funds own 91.94% of the company’s stock.
NGVT opened at $73.97 on Friday. Ingevity Co. has a 52-week low of $63.43 and a 52-week high of $89.55. The company has a quick ratio of 1.99, a current ratio of 2.91 and a debt-to-equity ratio of 1.95. The company has a market cap of $2.91 billion, a P/E ratio of 21.63 and a beta of 2.13. The firm’s 50-day moving average price is $75.00 and its 200-day moving average price is $77.29.
A number of analysts recently weighed in on NGVT shares. Zacks Investment Research lowered shares of Ingevity from a “hold” rating to a “strong sell” rating and set a $63.00 price objective for the company. in a research note on Monday, December 13th. TheStreet lowered shares of Ingevity from a “b” rating to a “c” rating in a research note on Wednesday, October 27th. Loop Capital reduced their target price on shares of Ingevity from $92.00 to $81.00 and set a “hold” rating for the company in a report on Thursday, November 18th. Finally, Wells Fargo & Company boosted their target price on shares of Ingevity from $82.00 to $84.00 and gave the stock an “equal weight” rating in a report on Friday, October 29th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $87.00.
Ingevity Corp. engages in the manufacture of specialty chemicals and carbon materials. It operates through the following segments: Performance Chemicals and Performance Materials. The Performance Materials segment consists of automotive technologies and process purifications product families. Automotive technologies produces automotive carbon products used in gasoline vapor emission control systems in cars, trucks, motorcycles and boats.
Recommended Story: How to find the components of the quick ratio
Want to see what other hedge funds are holding NGVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ingevity Co. (NYSE:NGVT).
Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.